FOR IMMEDIATE RELEASE:
May 7, 2004

UC DAVIS M.I.N.D. INSTITUTE HOSTS DISTINGUISHED LECTURE SERIES FOR 2003 - 2004

Pfiffner and McBurnett to speak on attention deficit hyperactivity disorder

(SACRAMENTO, Calif.) — The UC Davis M.I.N.D. Institute will host Linda Pfiffner and Keith McBurnett, professors of psychiatry at the University of California, San Francisco, on Wednesday, May 12, at the M.I.N.D. Institute, 2825 50th St., Sacramento, for the penultimate session in this year’s Distinguished Lecturer Series.

Pfiffner and McBurnett are nationally recognized for their research on attention deficit hyperactivity disorder (ADHD), its diagnosis, subtypes and response to intervention. Each will present a lecture. At 4:00 pm, McBurnett will discuss the ever-changing definitions of ADHD and current efforts to reduce heterogeneity within the inattentive subtype of this disorder. At 6:30 pm, Pfiffner will present recent results from the Child Life Skills Program, a multi-component psychosocial intervention involving teachers, parents, and children. She will also describe the efficacy of specific behavioral strategies for improving daily living and social skills in children with ADHD. Both presentations are free and open to the public; no reservations are needed.

Pfiffner heads the new Hyperactivity, Attention and Learning Problems Clinic at the University of California, San Francisco, a comprehensive program designed to provide evaluations and treatment recommendations. Pfiffner’s research and clinical interests focus on ADHD, particularly psychosocial interventions and family factors that predict the development of co-occurring disorders among children with ADHD. She has published a series of articles on school-based interventions for ADHD and a practical handbook for teachers working with children with ADHD. McBurnett, a child clinical psychologist, maintains an active clinical research program focusing on diagnostic categorization and on hormonal factors in child psychopathology. His work linking chronically low cortisol to persistent conduct disorder has been widely disseminated. He recently completed a clinical trial of medication for adolescents with hyperactivity disorder.
The final speaker in this year’s Distinguished Lecturer Series is Christopher Gillberg (June 9). Details about next year’s series will be available shortly.

For more information about this and future lectures, visit the M.I.N.D. Institute’s Web site or contact the Institute at (916) 703-0280.


MEDIA CONTACT:
Jennifer Conradi, Medical News Office, (916) 734-9064

Health System | School of Medicine | Medical Center | Medical Group